Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Retinoblastoma × Thiotepa × Clear all

Phase

Status

Terminated 2 Completed 2 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Myelodysplastic Syndromes 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia, Myeloid, Acute 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Lymphoma, Non-Hodgkin 4 Leukemia, Myelomonocytic, Juvenile 3 Multiple Myeloma 2 Lymphoma 2 Leukemia, Biphenotypic, Acute 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Shwachman-Diamond Syndrome 1 Sarcoma, Myeloid 1 Retinoblastoma 1 Primary Immunodeficiency Diseases 1 Neutropenia, Severe Congenital, Autosomal Recessive 3 1 Myelodysplastic-Myeloproliferative Diseases 1 Medulloblastoma 1 Macrophage Activation Syndrome 1 Lymphoproliferative Disorders 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphohistiocytosis, Hemophagocytic 1 Leukemia, Large Granular Lymphocytic 1 Leukemia 1 Histiocytosis, Langerhans-Cell 1 Histiocytosis 1 Hemoglobinopathies 1 Ganglioneuroblastoma 1 Breast Neoplasms 1 Bone Marrow Failure Disorders 1

Interventions

Vincristine 2 Etoposide 2 Cyclophosphamide 2 Carboplatin 2 trioctyl phosphine oxide 1 pembrolizumab 1 pegfilgrastim 1 Topotecan 1 Thiotepa 1 Surveys and Questionnaires 1 Observation 1 Mesna 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Eye Enucleation 1 Doxorubicin 1 Cytapheresis 1 Cryotherapy 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02870907 2026-01-07

RB SFCE 09

Institut Curie

Phase 2 Active not recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡